Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. It is grouped under the following drug class(es): Hypnotics, Neurotransmitter agents, Psychotropic agents, Schedule IV controlled substances and Sedatives. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sonata and Staccato-zaleplon. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 5719.
Zaleplon
| CAS No | 151319-34-5 |
|---|---|
| Molecular Formula | C17H15N5O |
| Molecular Weight | 305.33 g/mol |
| Synonyms | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines.
The listed CAS number is 151319-34-5.
The listed molecular formula is C17H15N5O.
The listed molecular weight is 305.33 g/mol.
N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide.
The source lists Sonata and Staccato-zaleplon.